NEW YORK (GenomeWeb News) – Thermo Fisher Scientific late on Thursday priced its offering of $800 million of senior notes at 99.991 percent of the principal amount.
The issuance of the notes is expected to close on or about Nov. 14, the company said. Net proceeds will be used primarily to repay debt, including the $400 million principal amount of its 3.25 percent senior notes due 2014 that mature on Nov. 20.
The joint book-running managers for the offering are Merrill Lynch, Pierce, Fenner & Smith; Mitsubishi UFJ Securities; Citigroup Global Markets; and Credit Suisse Securities.
Thermo Fisher announced its plans to offer the dollar-denominated senior notes on Thursday and said that it may also offer euro-denominated senior notes before the end of the year. Fitch Ratings gave the senior notes a BBB rating and said the rating outlook is negative.